European Journal of Chemistry

Synthesis and biological evaluation of phthalimide dithiocarbamate and dithioate derivatives as anti-proliferative and anti-angiogenic agents-I

Main Article Content

Magdy Zahran
Hussein Agwa
Amany Osman
Sherif Hammad
Bishoy El-Aarag
Nasser Ismail
Tarek Salem
Amira Gamal-Eldeen


A facile synthesis of new phthalimide dithiocarbamate and dithioate analogs 8a-j, 9a-e and 9g-j were achieved by the reaction of N-chloromethyl and N-bromoethylphthalimide with carbon disulfide (CS2) and various amines. The structures of the synthesized analogs were elucidated by spectroscopic methods, including IR, 1H NMR and 13C NMR, and ESI-HRMS techniques. The antiproliferative activity of the newly synthesized compounds was also evaluated against various human cancer cell lines. The compound 9e and 9i exhibited the highest activity against human breast adenocarcinoma MCF-7 and hepatocellular carcinoma HepG2 cells. Compound 8f showed better antiproliferative effect against colon carcinoma HCT-116 and cervical carcinoma HeLa compared to thalidomide. The binding affinity to vascular endothelial growth factor receptor (VEGFR) of some compounds was assessed in addition to molecular docking study. Compounds 9e and 9i showed high docking score values and they significantly declined the concentration of VEGFR.

icon graph This Abstract was viewed 1857 times | icon graph Article PDF downloaded 718 times

How to Cite
Zahran, M.; Agwa, H.; Osman, A.; Hammad, S.; El-Aarag, B.; Ismail, N.; Salem, T.; Gamal-Eldeen, A. Synthesis and Biological Evaluation of Phthalimide Dithiocarbamate and Dithioate Derivatives As Anti-Proliferative and Anti-Angiogenic Agents-I. Eur. J. Chem. 2017, 8, 391-399.

Article Details

Crossref - Scopus - Google - European PMC

[1]. Eger, K.; Jalalian, B.; Verspohl, E. J.; Lupke, N. P. Arzneim Forsch 1990, 40, 1073-1075.

[2]. Folkman, J. Ann. Int. Med. 1975, 82, 96-100.

[3]. Bartlett, J. B.; Dredge, K.; Dalgleish, A. G. Nat. Rev. Cancer 2004, 4, 314-322.

[4]. Juliussin, G.; Celsing, F.; Tursson, I.; Lenhoff, S.; Adriansson, M.; Malm, C. Br. J. Haematol. 2000, 109, 89-96.

[5]. Hashimoto, Y. Arch. Pharm. 2008, 341, 536-547.

[6]. Chan, S. H.; Lam, K. H.; Chui, C. H.; Gambari, R.; Yuen, M. C.; Wong, R. S.; Cheng, G. Y.; Lau, F. Y.; Au, Y. K.; Cheng, C. H.; Lai, P. B.; Kan, C. W.; Lung-Kok, S. H.; Tang, J. C.; Chan, A. S. Eur. J. Med. Chem. 2009, 44, 2736-2740.

[7]. Sondhi, S. M.; Rani, R.; Roy, P.; Agrawal, S. K.; Saxena, A. K. Bioorg. Med. Chem. Lett. 2009, 19, 1534-1538.

[8]. Zahran, M. A.; Salem, T. A.; Samaka, R. M.; Agwa, H. S.; Awad, A. R. Bioorg. Med. Chem. 2008, 16, 9708-9718.

[9]. Guirgis, A. A.; Zahran, M. A.; Mohamed, A. S.; Talaat, R. M.; Abdou, B. Y.; Agwa, H. S. Int. Immunopharmacol. 2010, 10, 806-811.

[10]. Talaat, R.; El-Sayed, W.; Agwa, H.; Gamal-Eldeen, A. M.; Moawia, S.; Zahran, M. Biomed. Aging. Pathol. 2014, 4, 179-189.

[11]. Zahran, M.; Gamal-Eldeen, A. M.; El-Hussieny, E. A.; Agwa, H. J. Genet. Eng. Biotech. 2014, 12, 65-70.

[12]. El-Aarag, B. Y. A.; Kasai, T.; Zahran, M. A. -H.; Zakhary, N. I.; Shigehiro, T.; Sekhar, S. C.; Agwa, H. S.; Mizutani, A.; Murakami, H.; Kakuta, H.; Seno, M. Int. Immunopharmacol. 2014, 21, 283-292.

[13]. Talaat, R.; El-Sayed, W.; Agwa, H.; Gamal-Eldeen, A. M.; Moawia, S.; Zahran, M. Chem. Biol. Interact. 2015, 238, 74-81.

[14]. El-Aarag, B.; Kasai, T.; Masuda, J.; Agwa, H.; Zahran, M.; Seno, M. Biomed. Pharmacother. 2017, 85, 549-555.

[15]. Ronconi, L.; Marzano, C.; Zanello, P.; Corsini, M.; Miolo, G.; Macca, C.; Trevisan, A.; Fregona, D. J. Med. Chem. 2006, 49, 1648-1657.

[16]. Ozkirimli, S.; Apak, T. I.; Kiraz, M.; Yegenoglu, Y. Arch. Pharm. Res. 2005, 28, 1213-1218.

[17]. Huang, W.; Ding, Y.; Miao, Y.; Liu, M. Z.; Yang, G. F. Eur. J. Med. Chem. 2009, 44, 3687-3696.

[18]. Cao, S. L.; Feng, Y. P.; Jiang, Y. Y.; Liu, S. Y.; Ding, G. Y.; Li, R. T. Bioorg. Med. Chem. Lett. 2005, 15, 1915-1917.

[19]. Zahra, M.; Osman, A.; Agwa, H.; Nair, N.; Sanchez, A.; Hurley, L.; Farag, D.; Kasai, T.; Seno, M.; Zahran, M. Med. Chem. 2016, 6(12), 694-703.

[20]. Zahran, M.; Abdin, Y.; Salama, H. Arkivoc 2008, 11, 256-265.

[21]. Zahran, M.; Salama, H. F.; Abdin, Y. G.; Gamal-Eldeen, A. M. J. Chem. Sci. 2010, 122, 587-595.

[22]. Zahran, M. A.; Abdin, Y. G.; Osman, A. M.; Gamal-Eldeen, A. M.; Talaat, R. M.; Pedersen, E. B. Arch. Pharm. Chem. 2014, 347, 1-8.

[23]. Shaohua, G.; Wenkang, H.; Jian, Z.; Yonghua, W. Bioorg. Med. Chem. Lett. 2015, 25, 3464-3467.

[24]. Hansen, M. B.; Nielsen, S. E.; Berg, K. J. Immunol. Methods 1989, 119, 203-210.

[25]. Talaat, R. M. Viral Immunol. 2010, 23, 151-157.

[26]. Cho, S. D.; Hwang, J.; Kim, H. K.; Yim, H. S.; Kim, J. J.; Lee, S. G.; Yoon, Y. J. J. Heterocycl. Chem. 2007, 44, 951-960.

[27]. Fhid, O.; Doma, A. M.; Zeglam, T. H.; Baki, J.; Zitouni, M.; Sdera, W. Der Pharma Chem. 2015, 7(11), 240-242.

[28]. Hess, S.; Akermann, M. A.; Wnendt, S.; Zwingenberger, K.; Eger, K. Bioorg. Med. Chem. 2001, 9, 1279-1291.

[29]. Norman, M. H.; Minick, D. J.; Rigdon, G. C. J. Med. Chem. 1996, 39, 149-157.

[30]. Salzberg, P. L.; Supniewski, J. V. Org. Synth. 1927, 7, 8-8.

[31]. Yabu, T.; Tomimoto, H.; Taguchi, Y.; Yamaoka, S.; Igarashi, Y.; Okazaki, T. Blood 2005, 106 (1), 125-134.

[32]. Rafiee, P.; Stein, D. J.; Nelson, V. M.; Otterson, M. F.; Shaker, R.; Binion, D. G. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298, 167-176.

[33]. Prager, G. W.; Poettler, M.; Unseld, M.; Zielinski, C. C. Transl. Lung Cancer Res. 2012, 1, 14-25.

[34]. Hasegawa, M.; Nishigaki, N.; Washio, Y.; Kano, K.; Harris, P. A.; Sato, H.; Mori, I.; West, R. I.; Shibahara, M.; Toyoda, H.; Wang, L.; Nolte, R. T.; Veal, J. M.; Cheung, M. J. Med. Chem. 2007, 50, 4453-4470.

[35]. Elgazwy, A. S.; Ismail, N. S.; Elzahabi, H. S. Bioorg. Med. Chem. 2010, 18, 7639-7650.

[36]. Alley, M. C.; Scudiero, D. A.; Monks, A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Cancer Res. 1988, 48, 589-601.

[37]. Kar, R. K.; Suryadevara, P.; Sahoo, B. R.; Sahoo, G. C.; Dikhit, M. R.; Das, P. SAR QSAR Environ Res. 2013, 24, 215-234.

[38]. Sharad, V.; Amit, S.; Abha, M. J. Appl. Pharma. Sci. 2012, 2, 41-46.

[39]. Paul, M. K.; Mukhopadhyay, A. K. Int. J. Med. Sci. 2004, 1, 101-115.

[40]. Krier, M.; Araujo-Junior, J. X.; Schmitt, M.; Duranton, J.; Justiano-Basaran, H.; Lugnier, C.; Bourguignon, J. J.; Rognan, D. J. Med. Chem. 2005, 48, 3816-3822.

[41]. Kamal, A.; Ramu, R.; Tekumalla, V.; Khanna, G. B.; Barkume, M. S.; Juvekar, A. S.; Zingde, S. M. Bioorg. Med. Chem. 2008, 16, 7218-7224.

[42]. Wang, X. L.; Wan, K.; Zhou, C. H. Eur. J. Med. Chem. 2010, 45, 4631-4639.

Supporting Agencies

Science and Technology Development Fund (STDF) through Project No. 3627 (Egyptian fund), Prof. Erik Pedersen, Department of Physics, Chemistry and Pharmacy, Nucleic Acid Center, University of Southern Denmark, Odense, Denmark.
Most read articles by the same author(s)

Dimensions - Altmetric - scite_ - PlumX

Downloads and views


Download data is not yet available.


Metrics Loading ...
License Terms

License Terms


Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License ( By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License ( are administered by Atlanta Publishing House LLC (European Journal of Chemistry).